Guardant Health, Inc. (GH)
Healthcare • Diagnostics & Research
StockNasdaqGSUnited StatesUS40131M1099
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Guardant Health, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 12 Nov 2026 21:26. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 18 Feb 2027 16:00 | -0.30 | — | — | Upcoming |
| 05 Nov 2026 16:00 | -0.31 | -0.29 | +6.4% | Beat |
| 30 Jul 2026 16:00 | -0.39 | -0.42 | -7.8% | Miss |
| 07 May 2026 16:00 | -0.47 | -0.45 | +5.0% | Beat |
| 19 Feb 2026 16:00 | -0.47 | -0.50 | -6.5% | Miss |
| 29 Oct 2025 16:00 | -0.49 | -0.39 | +20.3% | Beat |
| 30 Jul 2025 16:00 | -0.51 | -0.44 | +14.5% | Beat |
| 30 Apr 2025 16:00 | -0.59 | -0.49 | +17.0% | Beat |
| 20 Feb 2025 16:00 | -0.50 | -0.62 | -23.1% | Miss |
| 06 Nov 2024 16:00 | -0.60 | -0.45 | +24.4% | Beat |
| 07 Aug 2024 16:00 | -0.61 | -0.48 | +21.0% | Beat |
| 09 May 2024 16:00 | -0.73 | -0.46 | +37.0% | Beat |
| 22 Feb 2024 16:00 | -0.75 | -0.64 | +14.2% | Beat |
| 06 Nov 2023 16:00 | -0.80 | -0.67 | +15.9% | Beat |
| 03 Aug 2023 16:00 | -0.93 | -0.82 | +11.5% | Beat |
| 09 May 2023 16:00 | -1.07 | -1.06 | +1.1% | Beat |
| 23 Feb 2023 16:00 | -1.16 | -1.17 | -1.1% | Miss |
| 03 Nov 2022 16:00 | -1.08 | -1.18 | -9.4% | Miss |
| 04 Aug 2022 16:00 | -0.97 | -1.00 | -3.3% | Miss |
| 05 May 2022 16:00 | -1.10 | -0.91 | +17.5% | Beat |
| 23 Feb 2022 16:00 | -1.08 | -1.15 | -6.1% | Miss |
| 04 Nov 2021 16:00 | -0.87 | -1.06 | -21.5% | Miss |
| 05 Aug 2021 16:00 | -0.83 | -0.96 | -15.1% | Miss |
| 06 May 2021 16:00 | -0.83 | -1.09 | -31.2% | Miss |
| 24 Feb 2021 16:00 | -0.47 | -0.94 | -99.1% | Miss |
| 05 Nov 2020 16:00 | -0.36 | -0.78 | -118.7% | Miss |
| 06 Aug 2020 16:00 | -0.36 | -0.57 | -58.2% | Miss |
| 07 May 2020 17:00 | -0.39 | -0.29 | +25.2% | Beat |
| 24 Feb 2020 16:00 | -0.30 | -0.27 | +11.3% | Beat |
| 07 Nov 2019 16:00 | -0.37 | -0.14 | +62.6% | Beat |
| 06 Aug 2019 16:00 | -0.35 | -0.13 | +62.8% | Beat |
| 09 May 2019 16:00 | -0.37 | -0.30 | +18.8% | Beat |
| 12 Mar 2019 16:00 | -0.35 | -0.30 | +14.9% | Beat |
| 19 Nov 2018 16:00 | -0.29 | -0.29 | +3.1% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 982M | +32.9% | -416.3M | -42.4% | -3.32 | +6.7% | -233.1M |
| 2024 | 739M | +31.0% | -436.4M | -59.0% | -3.56 | +16.8% | -274.9M |
| 2023 | 563.9M | +25.5% | -479.4M | -85.0% | -4.28 | +33.2% | -345.5M |
| 2022 | 449.5M | — | -654.6M | -145.6% | -6.41 | — | -386.9M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 155.68 | 159.07 | 153.35 | 154.86 | +0.05% | 3,333,725 | |
| 11 Nov 2026 | 157.11 | 163.39 | 153.41 | 154.78 | -0.37% | 1,524,600 | |
| 10 Nov 2026 | 158.71 | 160.95 | 153.00 | 155.35 | -2.17% | 2,429,900 | |
| 09 Nov 2026 | 152.78 | 162.96 | 149.40 | 158.79 | +5.25% | 3,142,500 | |
| 06 Nov 2026 | 141.83 | 152.60 | 136.42 | 150.87 | -1.67% | 5,513,600 | |
| 05 Nov 2026 | 165.00 | 165.10 | 151.92 | 153.43 | -8.99% | 4,075,500 | |
| 04 Nov 2026 | 176.49 | 177.77 | 167.25 | 168.58 | -3.67% | 2,267,600 | |
| 03 Nov 2026 | 172.96 | 178.38 | 167.31 | 175.00 | +2.50% | 1,850,700 | |
| 02 Nov 2026 | 179.50 | 180.05 | 167.94 | 170.73 | -4.51% | 2,389,100 | |
| 30 Oct 2026 | 182.48 | 185.65 | 175.44 | 178.80 | -3.51% | 1,502,100 | |
| 1,250 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Guardant Health Prices $500 Million Convertible Senior Notes Offering (opens in a new tab) 12 Nov 2026 06:09
- Could You Have Seen The Run In Guardant Health Stock Coming? (opens in a new tab) Trefis · 11 Nov 2026 21:34
- Guardant Health Announces Proposed $500.0 Million Offering of Convertible Senior Notes Due 2032 (opens in a new tab) 11 Nov 2026 21:17
- Guardant Health Introduces New Epigenomic Applications Providing Deeper Insights for Treatment Selection with Guardant360® Liquid (opens in a new tab) 11 Nov 2026 13:46
- PRECISION Study Published in ESMO Open Highlights Utility of Guardant360® Liquid and Guardant Reveal® to Assess Recurrence Risk After Surgery for Colorectal Cancer Metastases (opens in a new tab) 10 Nov 2026 21:05
- Guardant Health, Inc. 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 10 Nov 2026 18:14
- Piper Sandler Maintains Overweight on Guardant Health, Lowers Price Target to $190 (opens in a new tab) Benzinga · 10 Nov 2026 08:55
- Guardant Health to Participate in Upcoming Investor Conferences (opens in a new tab) 09 Nov 2026 21:30
- GH Q3 2026 deep dive: new product launches and coverage wins drive growth, but market cautious on profitability (opens in a new tab) StockStory · 09 Nov 2026 10:05
- This cancer-testing stock is BTIG’s top pick after another major earnings beat (opens in a new tab) Investing.com · 09 Nov 2026 02:38
- Guardant Health (GH) Now Has A Harder Patent Fight After 23 Claims Survived (opens in a new tab) Simply Wall St. · 07 Nov 2026 23:10
- It Was Already A Gory Day For Blood-Testing Stocks — Then, Natera And Guardant Reported (opens in a new tab) Investor's Business Daily · 06 Nov 2026 21:10
- Guardant Health Stocks Fall 9.49% as Cash Burn Outlook Rises Despite 36% Growth (opens in a new tab) GuruFocus.com · 06 Nov 2026 16:59
- Guardant Health, Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 06 Nov 2026 13:30
- Guardant Health Shares Fall 5.5% as Higher Cash Burn Forecast Overshadows Strong Q3 Revenue Growth (opens in a new tab) InvestorsHub · 06 Nov 2026 11:22
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 154.78 USD
- Market cap
- 21.5B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow GH and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.